Revolutionizing Treatment Options

Three years ago, John Murphy was told he had less than six months to live. Undetected skin cancer had become stage IV melanoma and the once vibrant, active father of two was soon barely able to walk.

As his symptoms continued to worsen, John learned about a successful clinical trial at Mass General that was testing drug therapies for his specific form of cancer. He immediately inquired about the clinical trial, and traveled from his Colorado home to Boston to undergo treatment.

Today, John is hiking the mountain trails he loves again, thanks to the revolutionary cancer treatment being developed here at Mass General. This research was supported by the generosity of employees like you.

Please watch the video below to hear John’s inspirational story and learn how your giving helps fuel groundbreaking science.

Your gift to the MGH Fund supports Mass General’s transformational advances in the treatment of diseases like melanoma. Please consider the impact your contribution in any amount can have in helping Mass General meet health care’s most pressing challenges and promising opportunities as we continue to work together to save lives every day.

Make Your Gift Today!